UPCC 11125: The MILES Study: A Mixed-Methods Metabolomics Investigation of Lifestyle and Energy Balance During Breast Cancer Survivorship (MILES)

Lifestyle and Energy Balance in Breast Cancer Survivorship

UPCC 11125: The MILES Study: A Mixed-Methods Metabolomics Investigation of Lifestyle and Energy Balance During Breast Cancer Survivorship
Enrolling By Invitation
18 years or above
Female
Phase N/A
100 participants needed
1 Location

Brief description of study

The MILES Study is a longitudinal, mixed-methods investigation of urinary biomarkers, energy balance, and lifestyle modifications in diverse women during early breast cancer treatment. The study's overarching goal is to assess dietary quality and physical activity changes over time using reliable, scalable tools suitable for clinical or population settings, supporting newly diagnosed patients in adopting and maintaining healthy behaviors through treatment and survivorship.

Detailed description of study

Quantitative intervention: The study team will recruit adult women (age 18 years or older), who can read English or Spanish, have received a new diagnosis of breast cancer (stage 0-III) in the past 60 days, and have been scheduled to consult with a Penn surgeon.

Among a sample of 100 women with newly diagnosed breast cancer, the study team will collect novel lifestyle behavior data across three time points-at diagnosis, 1 month after surgery, and 6 months after surgery. Surveys will evaluate dietary quality, physical activity, tobacco use, demographic and socio-economic/occupation factors and perspectives about participation in biomedical/biospecimen research. The study team will also collect the first urine of the day from these volunteers on the same day that they complete the lifestyle questionnaires. The urine will be used for metabolomics testing via Nuclear Magnetic Resonance (NMR) spectroscopy and will be correlated with the survey data.

Qualitative intervention: Among a subset of 50 women, the study team will conduct semi-structured interviews at baseline and at follow-up to answer the following research questions:

  1. What structural and interpersonal factors influence the adoption and maintenance of a healthy lifestyle after diagnosis and after each phase of treatment?
  2. What is the role of financial hardship on lifestyle behaviors after diagnosis?
  3. How do lifestyle behaviors change after surgery or systematic therapy?
  4. What are the barriers/facilitators to participation in urine biospecimen donation?
  5. Identify patient-identified strategies that would facilitate more effective translation and dissemination of lifestyle data for patients
  6. Promote or increase usability and promote behavior change?
  7. What modalities of metabolomics-based intervention delivery are best
  8. What is the optimal timing for intervention?

Eligibility of study

You may be eligible for this study if you meet the following criteria:

  • Conditions: Breast Cancer
  • Age: 18 years or above
  • Gender: Female

Inclusion Criteria:

  • Adult women (age 18 years or older)
  • Able to read English or Spanish
  • Newly diagnosed with primary stage 0, I, II, or III breast cancer
  • Pathological diagnosis within the previous 60 days
  • Scheduled to have surgery with a Penn Medicine surgeon

Exclusion Criteria:

  • Women age less than 18 years
  • Women without a new primary breast cancer diagnosis
  • Women who are pregnant

This study investigates breast cancer. It focuses on understanding lifestyle and energy balance in women during early treatment stages.

The study evaluates dietary quality and physical activity over time. It also looks at how these factors can support healthy behaviors in patients.

  • Who can participate: Adult women aged 18 years or older who can read English or Spanish and have been newly diagnosed with stage 0-III breast cancer within the past 60 days are eligible. Participants must be scheduled for surgery with a Penn Medicine surgeon.
  • Study details: Participants will provide urine samples and complete lifestyle questionnaires at specific times. Some will also participate in interviews. A placebo is not used in this study.
Updated on 24 Jun 2026. Study ID: 25-0855
If you need assistance finding a non-cancer clinical research study or if you have any questions, please email psom-ocr@pobox.upenn.edu For Cancer trials contact Penn Medicine's Cancer Trial Navigator at: PMCancerResearch@pennmedicine.upenn.edu or 215-349-8245

Study is selecting its participants from a population, or group of people, decided on by the researchers in advance.

Contact Abramson Cancer Center Navigator